Beijing-based healthcare investment firm Sherpa Healthcare Partners has reached the final close of its oversubscribed maiden U.S. dollar fund to make equity investments in early and growth-stage investments in the fields of biomedicines, medical diagnostic devices, and healthcare services.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
